Ginger-based agents for delaying the onset of metabolic syndrome: type-2 diabetes and dyslipidemia

用于延缓代谢综合征发作的姜类药物：2 型糖尿病和血脂异常

• 批准号: LP0989786
• 负责人: Prof Basil Roufogalis
• 金额: $ 16.08万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-03-12 至 2012-03-11
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0989786
• 关键词: Ginger; based; agents; delaying; onset

We will determine the potential of ginger, a relatively safe and popular food and spice, to be developed as a preventative nutraceutical agent to delay the onset of type 2 diabetes and its complications. Our research will allow us to formulate a standardised ginger preparation of known mechanism of action that delivers safe and reproducible effects The project has the capacity to reduce the debilitating effects of type 2 diabetes in the nation's health and its high economic costs, and to improve the quality of life of the Australian community, more than 1 million of whom are affected by this growing epidemic.

我们将确定生姜作为一种相对安全和流行的食品和香料的潜力，将其开发为预防性营养药物，以延迟2型糖尿病及其并发症的发病。我们的研究将使我们能够制定一个标准化的生姜制剂已知的作用机制，提供安全和可重复的效果该项目有能力减少2型糖尿病在国家的健康和高经济成本的衰弱影响，并提高澳大利亚社区的生活质量，其中超过100万人受到这种日益增长的流行病的影响。